Dr. Joshua Michael Sill, MD

Dr. Sill practices at Sentara Norfolk General Hospital in Norfolk, Virginia, part of Sentara Health.

Dr. Sill's NPI, 1679696744, was assigned on April 6, 2007. Dr. Sill graduated from University of Texas Medical Branch at Galveston in 2002. Dr. Sill holds Virginia license 0101253309.

Dr. Sill's primary practice is Sentara Norfolk General Hospital, at 600 Gresham Dr, Norfolk, VA 23507 in Norfolk City. The practice phone is (757) 388-3000.

Dr. Sill's primary practice is Sentara Norfolk General Hospital in Norfolk, Virginia, part of Sentara Health. Dr. Sill is also affiliated with Sentara Leigh Hospital. The medical group on file is EVMS Medical Group. Dmand AI also links Dr. Sill to 1 more hospital, 3 group practices and clinics, 2 medical groups and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sill practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Sill's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Sill is licensed in Virginia.

CMS data shows 556 Medicare services from Dr. Sill across 12 procedure codes in 2024, for 258 Medicare patients. Medicare paid $34,975 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 258 Medicare patients who saw Dr. Sill in 2024. The largest group is 65 to 74, with 102 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sill's median patient age at 61, with 56% women.

In 2024, Dr. Sill wrote 493 Medicare Part D claims for 70 patients. 41% of them were for generic drugs. CMS names the drug for 367 of them, across 13 drugs with 11 or more claims each, at $1,167,097 in total drug cost. In 2023, CMS named 267 claims across 12 drugs.

Dr. Sill accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Sill, published from 2015 to 2023. 2023 was the busiest year, with 3. The most frequent topics are Lung, Carrier Proteins and Membrane Proteins. Dr. Sill has published most often in Am J Respir Cell Mol Biol. Dr. Sill's most frequent co-authors are John W. Christman, MD, Michael H. Hooper, MD and Rolf D. Hubmayr, MD.

CMS Open Payments shows 162 general payments to Dr. Sill from 17 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 74% of the total. Genentech, Inc. paid the most, $111,728.

Dr. Sill graduated from University of Texas Medical Branch at Galveston in 2002.